Accelrys Releases Three New Component Collections for SciTegic Pipeline Pilot(TM), the Scientific Operating Platform for Discovery and Development.
SAN DIEGO -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific business intelligence software and services, today announced the release of three new component collections for SciTegic Pipeline Pilot[TM], the platform for scientific discovery and development. The new component collections feature functionality in the areas of advanced image analysis, chemical mining and gene expression that make it easier to define and deploy protocols to a broader audience.
The Advanced Imaging Collection brings SciTegic Pipeline Pilot's powerful data integration capabilities to research and development workflows enabling unparalleled learning, clustering, modeling, statistical analysis, reporting and archiving of images, video and associated data. Template protocols allow rapid development of custom applications such as drill-down reporting and image link capabilities. With the SciTegic Pipeline Pilot open platform, almost any standard image file format can be accommodated for scientific, medical and industrial applications.
The ChemMining Collection allows scientists to mine and analyze the world's patent literature and find opportunities for new drug candidates. Similarly, it can be used to create a chemically aware knowledge base of internal documents to obtain a coherent understanding of current and past projects in large drug discovery organizations. The Collection facilitates the creation of flexible workflows that search text documents to find chemical names, convert them to live structures, and create a searchable chemical database.
The Gene Expression Collection empowers researchers to identify potential drug targets and biomarker candidates. With this Collection, scientists can process, analyze, explore, and report on gene expression experiments. Robust and flexible BioConductor-based workflows deliver automation and web-based bioinformatics solutions that allow increased productivity in research labs in biotechnology and pharmaceutical organizations.
"The tools in the new component collections extend the scientific operating platform by allowing a broader range of users access to the powerful processing and analysis tools in the platform's user-friendly graphical programming environment. This is another example of how Accelrys helps enable our customers to gain deeper insights and make more informed decisions based on their scientific data across the research and development continuum," said Mark J. Emkjer, President and Chief Executive Officer of Accelrys.
For more information about the new SciTegic Pipeline Pilot Collections, please visit http://accelrys.com/products/scitegic/.
About Accelrys, Inc.
Accelrys develops and commercializes scientific business intelligence software for the integration, mining, analysis, modeling and simulation, management and interactive reporting of scientific data. Our solutions are used by biologists, chemists, materials scientists, and information technology professionals for product design as well as drug discovery and development. Our technology and services are designed to meet the needs of today's leading research and development organizations including leading commercial, government and academic organizations. Many of the largest pharmaceutical, biotechnology, chemical, and petroleum companies worldwide use our solutions. Accelrys is headquartered in San Diego, California. For more information about Accelrys, visit its website at http://accelrys.com/.
This press release contains forward-looking statements. Such statements, including statements relating to SciTegic Pipeline Pilot and the Component Collections, including features and potential demand therefore, are subject to risks and uncertainties including, but not limited to, the risks that SciTegic Pipeline Pilot or the Component Collections will not be timely or successfully completed, developed, successfully include all features described herein, or achieve market acceptance, demand relating to SciTegic Pipeline Pilot and the Component Collections, and other risks and uncertainties described in documents Accelrys has filed with the Securities and Exchange Commission, including its most recent report on Form 10-K and any subsequent interim filings. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys disclaims any intent or obligation to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
|Printer friendly Cite/link Email Feedback|
|Date:||Mar 3, 2008|
|Previous Article:||Getting in the Game Boosts Health of Overweight Children, Stanford/Packard Study Shows.|
|Next Article:||RFMD Provides Update on Share Repurchase Program.|
|ACCELRYS TO PROVIDE 10,000 PROTEIN SEQUENCES.|
|INCYTE GENOMICS SIGNS AGREEMENT WITH ACCELRYS.|
|Digital Gene to use Accelrys' bioinformatics system.|
|Accelrys buys SciTegic.|